UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A.2 Identification of predictors of response to Erenumab in episodic and chronic migraine in a cohort of patients: a preliminary analysis

Canadian journal of neurological sciences, 2022-06, Vol.49 (s1), p.S3-S3

2022

Volltextzugriff (PDF)

A.5 Identification of predictors of response to Erenumab in episodic and chronic migraine in a cohort of patients: a preliminary analysis

Canadian journal of neurological sciences, 2021-11, Vol.48 (s3), p.S15-S15

2021

Volltextzugriff (PDF)

Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions

Neurology, 2006-04, Vol.66 (8), p.1248-1250

2006

Volltextzugriff (PDF)

Estimating Y Chromosome Specific Microsatellite Mutation Frequencies using Deep Rooting Pedigrees

Human molecular genetics, 1997-05, Vol.6 (5), p.799-803

1997

Volltextzugriff (PDF)

Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions

Gene therapy, 2003-05, Vol.10 (9), p.795-802

2003

Volltextzugriff (PDF)

P4.44 Methylphenidate reduces excessive daytime sleepiness in patients with myotonic dystrophy

Neuromuscular disorders : NMD, 2011-10, Vol.21 (9), p.717-718

2011

Volltextzugriff (PDF)

O.6 Antisense approach for myotonic dystrophy

Neuromuscular disorders : NMD, 2011-10, Vol.21 (9), p.681-681

2011

Volltextzugriff (PDF)

P5.8 The Quebec myotonic dystrophy-based population registry

Neuromuscular disorders : NMD, 2011-10, Vol.21 (9), p.726-726

2011

Volltextzugriff (PDF)

P.18.1 The DM-Scope registry: Interfacing myotonic dystrophy clinical care and research

Neuromuscular disorders : NMD, 2013-10, Vol.23 (9), p.832-832

2013

Volltextzugriff (PDF)

P4.29 Magnetic resonance identifies muscle wasting associated with fatty infiltration and loss of strength over an 18-month period in type 1 myotonic dystrophy

Neuromuscular disorders : NMD, 2010-10, Vol.20 (9), p.667-667

2010

Volltextzugriff (PDF)

A novel founder SCN4A mutation causes painful cold-induced myotonia in French-Canadians

Neurology, 2007-11, Vol.69 (20), p.1937-1941

2007

Volltextzugriff (PDF)

G.P.14.05 Quantitative isometric muscle strength at the ankle in myotonic dystrophy type 1 Patients: A discriminative biological marker

Neuromuscular disorders : NMD, 2009-09, Vol.19 (8), p.644-645

2009

Volltextzugriff (PDF)

Consensus-based care recommendations for adults with myotonic dystrophy type 1

Neurology. Clinical practice, 2018-12, Vol.8 (6), p.507-520

2018

Volltextzugriff (PDF)

Investigating neurological disorders in congenital myotonic dystrophy type 1 using 3-D forebrain organoids

Cytotherapy (Oxford, England), 2021-05, Vol.23 (5), p.S124-S124

2021

Volltextzugriff (PDF)

Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone

Glia, 1997-04, Vol.19 (4), p.324-332

1997

Volltextzugriff (PDF)

G.P.14.10 Inhibition of prostaglandin E2 (PGE2) production restores the differentiation of congenital human dystrophy myotonic type 1 (CDM1) myoblasts

Neuromuscular disorders : NMD, 2007, Vol.17 (9), p.857-857

2007

Volltextzugriff (PDF)

Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain

Neuroscience, 1996-11, Vol.75 (1), p.231-243

1996

Volltextzugriff (PDF)

P.396The DM-Scope registry: an innovative framework for myotonic dystrophy translational resarch

Neuromuscular disorders : NMD, 2019-10, Vol.29, p.S197-S197

2019

Volltextzugriff (PDF)

Sensibilité et spécificité du dosage de la thyréostimuline (TSH) sur papier filtre pour le diagnostic d'hypothyroïdie chez la personne âgée

Annales d'endocrinologie, 1997-05, Vol.58 (2), p.152-157

1997

Volltextzugriff (PDF)

Intracellular ribozyme applications

Biochemical Society transactions, 2002-11, Vol.30 (Pt 6), p.1140-1145

2002

Volltextzugriff (PDF)

P.436 - Associations between grip strength, myotonia and CTG expansion in myotonic dystrophy type 1

Neuromuscular disorders : NMD, 2017-10, Vol.27, p.S227-S227

2017

Volltextzugriff (PDF)

Associations between grip strength, myotonia and CTG expansion in myotonic dystrophy type 1

Neuromuscular disorders : NMD, 2017-10, Vol.27, p.S227

2017

Volltextzugriff (PDF)

P.387 - Patient-derived pluripotent stem cells: an in vitro model for neuromuscular diseases and high-throughput drug screening

Neuromuscular disorders : NMD, 2017-10, Vol.27, p.S213-S213

2017

Volltextzugriff (PDF)

Patient-derived pluripotent stem cells: an in vitro model for neuromuscular diseases and high-throughput drug screening

Neuromuscular disorders : NMD, 2017-10, Vol.27, p.S213

2017

Volltextzugriff (PDF)

G.P.10.15 Genotype–phenotype correlation and identification of new mutations in non-dystrophic myotonias

Neuromuscular disorders : NMD, 2007, Vol.17 (9), p.822-822

2007

Volltextzugriff (PDF)

1 – 25 von 257

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(249)
Mit Volltextzugriff
(223)

Publikationsform

Sprache

Englisch
(205)
Französisch
(54)

Erscheinungsjahr

n.n

Thema

Science & Technology
(87)
Life Sciences & Biomedicine
(86)
Humans
(64)
Biological And Medical Sciences
(53)
Animals
(52)
Neurosciences & Neurology
(45)
Neurosciences
(39)
Male
(38)
Female
(34)
Fundamental And Applied Biological Sciences. Psychology
(32)
Cells, Cultured
(31)
Rats
(28)
Life Sciences
(26)
Medical Sciences
(22)
Middle Aged
(22)
Neurology
(22)
Aged
(20)
Mice
(20)
Adult
(18)
Clinical Neurology
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A.2 Identification of predictors of response to Erenumab in episodic and chronic migraine in a cohort of patients: a preliminary analysis

A.5 Identification of predictors of response to Erenumab in episodic and chronic migraine in a cohort of patients: a preliminary analysis

Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions

Estimating Y Chromosome Specific Microsatellite Mutation Frequencies using Deep Rooting Pedigrees

Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions

P4.44 Methylphenidate reduces excessive daytime sleepiness in patients with myotonic dystrophy

O.6 Antisense approach for myotonic dystrophy

P5.8 The Quebec myotonic dystrophy-based population registry

P.18.1 The DM-Scope registry: Interfacing myotonic dystrophy clinical care and research

P4.29 Magnetic resonance identifies muscle wasting associated with fatty infiltration and loss of strength over an 18-month period in type 1 myotonic dystrophy

A novel founder SCN4A mutation causes painful cold-induced myotonia in French-Canadians

G.P.14.05 Quantitative isometric muscle strength at the ankle in myotonic dystrophy type 1 Patients: A discriminative biological marker

Consensus-based care recommendations for adults with myotonic dystrophy type 1

Investigating neurological disorders in congenital myotonic dystrophy type 1 using 3-D forebrain organoids

Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone

G.P.14.10 Inhibition of prostaglandin E2 (PGE2) production restores the differentiation of congenital human dystrophy myotonic type 1 (CDM1) myoblasts

Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain

P.396The DM-Scope registry: an innovative framework for myotonic dystrophy translational resarch

Sensibilité et spécificité du dosage de la thyréostimuline (TSH) sur papier filtre pour le diagnostic d'hypothyroïdie chez la personne âgée

Intracellular ribozyme applications

P.436 - Associations between grip strength, myotonia and CTG expansion in myotonic dystrophy type 1

Associations between grip strength, myotonia and CTG expansion in myotonic dystrophy type 1

P.387 - Patient-derived pluripotent stem cells: an in vitro model for neuromuscular diseases and high-throughput drug screening

Patient-derived pluripotent stem cells: an in vitro model for neuromuscular diseases and high-throughput drug screening

G.P.10.15 Genotype–phenotype correlation and identification of new mutations in non-dystrophic myotonias

Suchergebnisse filtern